MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2018 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
13 M |
Marktkapitalisierung |
$ 1.05 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market |  Britain |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX |  Russia |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | Britain |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Immunome
IMNM
|
$ 27.05 | 1.08 % | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
InMed Pharmaceuticals
INM
|
$ 1.36 | 3.76 % | $ 1.33 M | Nasdaq Capital Market |  Canada |
 |
Inovio Pharmaceuticals
INO
|
$ 1.42 | 0.35 % | $ 66.6 M | Nasdaq Global Select Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 5.19 | 0.68 % | $ 994 M | Nasdaq Global Select Market | Canada |
 |
Ionis Pharmaceuticals
IONS
|
$ 55.86 | 0.4 % | $ 8.94 B | Nasdaq Global Select Market,SPB | USA |
 |
Iovance Biotherapeutics
IOVA
|
$ 8.85 | 0.68 % | $ 3.16 M | Nasdaq Global Market,SPB | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 27.94 | 0.57 % | $ 4.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Jaguar Health
JAGX
|
$ 0.45 | 1.58 % | $ 1.05 M | Nasdaq Capital Market | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 243.0 | 0.22 % | $ 14.8 B | Nasdaq Global Select Market |  Irlanda |
 |
Johnson & Johnson
JNJ
|
$ 268.1 | 1.17 % | $ 645 B | NYSE,SPB | USA |
 |
Achieve Life Sciences
ACHV
|
$ 8.3 | 2.17 % | $ 362 M | Nasdaq Capital Market | USA |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 77.91 | 0.28 % | $ 5.78 B | Nasdaq Global Select Market | USA |
 |
Kodiak Sciences
KOD
|
$ 34.81 | 0.13 % | $ 1.85 B | Nasdaq Global Market,SPB | USA |
 |
Karyopharm Therapeutics
KPTI
|
$ 1.75 | 1.13 % | $ 19.1 K | Nasdaq Global Select Market | USA |
 |
Keros Therapeutics
KROS
|
$ 11.27 | 1.89 % | $ 419 M | Nasdaq Global Select Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 119.91 | 2.15 % | $ 10.1 B | Nasdaq Global Market | USA |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.14 | 4.61 % | $ 262 M | NYSE American | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
$ 280.29 | 0.98 % | $ 5.42 B | Nasdaq Global Select Market,SPB | USA |
 |
Longeveron
LGVN
|
$ 6.64 | 3.5 % | $ 117 B | Nasdaq Global Select Market | USA |
 |
Eli Lilly and Company
LLY
|
$ 1 121.89 | 0.03 % | $ 1.01 T | NYSE,SPB | USA |
 |
Adagene
ADAG
|
$ 3.58 | 0.14 % | $ 211 M | Nasdaq Global Market |  China |
 |
Lipocine
LPCN
|
$ 2.4 | 1.24 % | $ 13.1 M | Nasdaq Global Select Market | USA |
 |
Liquidia Corporation
LQDA
|
$ 67.92 | 0.5 % | $ 5.85 B | Nasdaq Capital Market | USA |
|
Larimar Therapeutics
LRMR
|
$ 3.87 | 0.91 % | $ 322 M | Nasdaq Global Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 2.22 | 0.89 % | $ 806 M | Nasdaq Global Select Market | USA |
 |
Adial Pharmaceuticals
ADIL
|
$ 6.98 | 6.91 % | $ 4.67 M | Nasdaq Capital Market | USA |
 |
Mustang Bio
MBIO
|
$ 0.54 | 3.28 % | $ 2.65 M | Nasdaq Global Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 0.79 | 10.59 % | $ 936 K | Nasdaq Global Select Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 5.72 | 1.42 % | $ 50.7 M | Nasdaq Global Select Market | USA |
 |
Mesoblast Limited
MESO
|
$ 16.55 | 1.05 % | $ 20 B | Nasdaq Global Select Market |  Australia |
 |
MacroGenics
MGNX
|
$ 4.35 | 3.53 % | $ 275 M | Nasdaq Global Select Market | USA |
 |
MeiraGTx Holdings plc
MGTX
|
$ 13.71 | 0.5 % | $ 1.1 B | Nasdaq Global Select Market | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 100.45 | 0.27 % | $ 5.04 B | Nasdaq Global Select Market | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 1.16 | 0.41 % | $ 123 M | Nasdaq Global Select Market | Canada |